Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07135323
AvertD Post-Approval Study
Sponsor: Prescient Medicine Holdings, Inc.
View on ClinicalTrials.gov
Summary
A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
4000
Start Date
2024-11-15
Completion Date
2031-11
Last Updated
2025-08-22
Healthy Volunteers
Yes
Conditions
Interventions
GENETIC
Opioid Used Disorder Risk Assessment
Determine the likelihood of Opioid Used Disorder prior to prescribing opioids
Locations (1)
Concentrics Research
Indianapolis, Indiana, United States